These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 18435634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?
    Fox DJ, Kibiro M, Eichhöfer J, Curzen NP.
    Postgrad Med J; 2005 Jun; 81(956):401-3. PubMed ID: 15937208
    [Abstract] [Full Text] [Related]

  • 4. Interventions to improve guideline compliance following coronary artery bypass grafting.
    Yam FK, Akers WS, Ferraris VA, Smith K, Ramaiah C, Camp P, Flynn JD.
    Surgery; 2006 Oct; 140(4):541-7; discussion 547-52. PubMed ID: 17011901
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
    Corp EV, Antoniou S, Wright PG, Khachi H, Vercaeren S, Wald DS.
    QJM; 2009 Dec; 102(12):843-9. PubMed ID: 19828644
    [Abstract] [Full Text] [Related]

  • 7. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED, PREVENT IV Investigators.
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [Abstract] [Full Text] [Related]

  • 8. Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials.
    Okrainec K, Platt R, Pilote L, Eisenberg MJ.
    J Am Coll Cardiol; 2005 Jan 18; 45(2):177-84. PubMed ID: 15653013
    [Abstract] [Full Text] [Related]

  • 9. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH, Bax JJ, Karagiannis SE, Noordzij P, van Domburg R, Klein J, Poldermans D.
    Arch Gerontol Geriatr; 2009 Jan 18; 48(1):116-20. PubMed ID: 18177954
    [Abstract] [Full Text] [Related]

  • 10. Long-term adherence with cardiovascular drug regimens.
    Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED.
    Am Heart J; 2006 Jan 18; 151(1):185-91. PubMed ID: 16368315
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of hospitalization period and five-year follow-up of patients admitted with acute coronary syndrome following coronary artery bypass graft surgery].
    Can LH, Kayıkçıoğlu M, Yavuzgil O, Kültürsay H, Soydan I.
    Turk Kardiyol Dern Ars; 2010 Sep 18; 38(6):387-92. PubMed ID: 21200116
    [Abstract] [Full Text] [Related]

  • 12. The use of an anesthesia information system to identify and trend gender disparities in outpatient medical management of patients with coronary artery disease.
    Vigoda MM, Rodríguez LI, Wu E, Perry K, Duncan R, Birnbach DJ, Lubarsky DA.
    Anesth Analg; 2008 Jul 18; 107(1):185-92. PubMed ID: 18635487
    [Abstract] [Full Text] [Related]

  • 13. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL, Chow KL, Looi JL, Lee M, Halliday S, White H, Ellis C.
    N Z Med J; 2011 Sep 23; 124(1343):18-27. PubMed ID: 21964009
    [Abstract] [Full Text] [Related]

  • 14. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F, CPACS Investigators.
    Am Heart J; 2009 Mar 23; 157(3):509-516.e1. PubMed ID: 19249422
    [Abstract] [Full Text] [Related]

  • 15. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec 23; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 16. Cardiac medical therapy among patients undergoing abdominal aortic aneurysm repair.
    Kurzencwyg D, Filion KB, Pilote L, Nault P, Platt RW, Rahme E, Steinmetz O, Eisenberg MJ.
    Ann Vasc Surg; 2006 Sep 23; 20(5):569-76. PubMed ID: 16794911
    [Abstract] [Full Text] [Related]

  • 17. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.
    Am J Med; 2004 Jul 15; 117(2):73-81. PubMed ID: 15234641
    [Abstract] [Full Text] [Related]

  • 18. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM, Ho PM, Roe M, Dai D, Tsai TT, Rumsfeld JS.
    Circ Cardiovasc Qual Outcomes; 2010 Nov 15; 3(6):632-41. PubMed ID: 20923997
    [Abstract] [Full Text] [Related]

  • 19. Medication performance measures and mortality following acute coronary syndromes.
    Granger CB, Steg PG, Peterson E, López-Sendón J, Van de Werf F, Kline-Rogers E, Allegrone J, Dabbous OH, Klein W, Fox KA, Eagle KA, GRACE Investigators.
    Am J Med; 2005 Aug 15; 118(8):858-65. PubMed ID: 16084178
    [Abstract] [Full Text] [Related]

  • 20. [Medical therapy in revascularized coronary artery disease patients].
    Liu XH, DU X, Kang JP, Lü Q, Zhang Q, Lü SZ, Chen F, Ma CS.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):236-9. PubMed ID: 18361833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.